Henry Charman ‘20 pitched CVS Health (CVS) on Monday, October 28, 2019. CVS Health is an integrated health services company providing a range of products and services to over 100 million commercial and government network clients. CVS’s offering portfolio includes cost management strategies for private and federal drug plan sponsors, a 68,000-store retail and specialty pharmacy network, and a variety of health insurance products serving over 42 million plan members following the company’s acquisition of insurer Aetna in November of 2018. Despite concern surrounding the 29% premium CVS paid in the $70 billion Aetna deal, CVS has been able to meet and even exceed near-term integration targets with Aetna in the first three quarters of 2019. Since hitting a 52-week low of $51.72 in March, CVS shares have recovered over 40% to $75.36 on December 6th. On October 28th, the class voted to fund the purchase of 225 shares of CVS with the sale of 50 shares of SPY.